72 related articles for article (PubMed ID: 25329108)
1. Potential value of in situ cellular immune response in HPV subtype 16 and 18 positive cervical cancer.
Ancuţa E; Buţureanu S; Zugun-Eloae F; Anton CR; Ancuţa C; Diţescu D; Anton E
Rom J Morphol Embryol; 2014; 55(3):817-22. PubMed ID: 25329108
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of cellular immune response in cervical cancer.
Ancuta E; Ancuţa C; Zugun-Eloae F; Iordache C; Chirieac R; Carasevici E
Rom J Morphol Embryol; 2009; 50(4):651-5. PubMed ID: 19942961
[TBL] [Abstract][Full Text] [Related]
3. Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression.
Ancuţa E; Ancuţa C; Cozma LG; Iordache C; Anghelache-Lupaşcu I; Anton E; Carasevici E; Chirieac R
Rom J Morphol Embryol; 2009; 50(3):413-8. PubMed ID: 19690767
[TBL] [Abstract][Full Text] [Related]
4. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.
Ueda M; Hung YC; Chen JT; Chiou SH; Huang HH; Lin TY; Terai Y; Chow KC
Gynecol Oncol; 2006 Aug; 102(2):173-81. PubMed ID: 16427687
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
[TBL] [Abstract][Full Text] [Related]
6. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
7. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
[TBL] [Abstract][Full Text] [Related]
8. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
9. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
10. Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy.
Kim JY; Park S; Nam BH; Roh JW; Lee CH; Kim YH; Shin HJ; Lee SK; Kong SY; Seong MW; Han TJ; Lee MY; Cho KH; Park SY
J Clin Oncol; 2009 Oct; 27(30):5088-93. PubMed ID: 19770372
[TBL] [Abstract][Full Text] [Related]
11. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME; Dalbert D; Picconi MA; Cúneo N; González J; Vornetti S; Bazán G; Mural J; Basiletti J; Teyssié AR; Alonio LV
J Med Virol; 2008 Apr; 80(4):694-701. PubMed ID: 18297710
[TBL] [Abstract][Full Text] [Related]
13. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
14. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Yugawa T; Kiyono T
Rev Med Virol; 2009 Mar; 19(2):97-113. PubMed ID: 19156753
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of two commercialised in situ hybridisation assays for detecting HPV-DNA in formalin-fixed, paraffin-embedded tissue.
Montag M; Blankenstein TJ; Shabani N; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Oct; 284(4):999-1005. PubMed ID: 21113720
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years.
Nedergaard BS; Ladekarl M; Nyengaard JR; Nielsen K
Gynecol Oncol; 2008 Jan; 108(1):106-11. PubMed ID: 17945335
[TBL] [Abstract][Full Text] [Related]
19. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
20. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
